• Latest
  • Trending
Coronavirus fact check

Coronavirus fact check

August 19, 2022
Lawrence – The Heartburn Song

Lawrence – The Heartburn Song

February 19, 2023
7 Steps to A Healthier You: Beat Heartburn!

7 Steps to A Healthier You: Beat Heartburn!

February 19, 2023
Heartburn No More: Enjoy Oatmeal Cookies Without Fear

Heartburn No More: Enjoy Oatmeal Cookies Without Fear

February 19, 2023
Say Goodbye to Heartburn and Acid Reflux

Say Goodbye to Heartburn and Acid Reflux

February 19, 2023
Delicious Ways to Avoid Heartburn

Delicious Ways to Avoid Heartburn

February 19, 2023
Burn, Baby, Burn!

Burn, Baby, Burn!

February 19, 2023
GERD or Heartburn? 6 Signs and When to See a Doctor

GERD or Heartburn? 6 Signs and When to See a Doctor

January 16, 2023
Eating regimen & Way of life Adjustments

Eating regimen & Way of life Adjustments

January 16, 2023
  • Contact
  • About
  • Advertise
  • Privacy & Policy
Sunday, April 2, 2023
  • Login
  • Home
  • Popular
  • Heartburn
  • Foods
  • Recipes
  • Tips
  • Researches
  • Video
No Result
View All Result
Heartburn Diet
Advertisement Banner
Heartburn Diet
No Result
View All Result
Premium domain NoStill.com is for sale
Home Heartburn

Coronavirus fact check

Is a common heartburn drug a treatment for the COVID-19 virus?

by admin
August 19, 2022
in Heartburn
Reading Time: 3 mins read
111 3
0
Coronavirus fact check
72
SHARES
1k
VIEWS
Share on FacebookShare on Twitter

A common heartburn drug being tested by a group of New York hospitals may show promise in treating the COVID-19 virus, according to a story from ABC News.

The hospitals, which have only just made the study public, have been testing the effectiveness of famotidine, the active ingredient in over-the-counter heartburn medications like Pepcid.

Hospitals in the Northwell Health network in the New York City area have been using large doses of famotidine in IV form to treat patients critically ill with the COVID-19 virus. The 187 patients in the study group have been given daily doses of famotidine roughly nine times the dose prescribed for heartburn.

The medicine is given in combination with the drug hydroxychloroquine, the anti-malaria drug that President Donald Trump has touted as a medication that shows great promise as a treatment for the virus.

The first COVID-19 patients at Northwell Health in the New York City area began receiving famotidine intravenously on April 7 after Northwell gained permission from the U.S. Food and Drug Administration and after about half of the vials of the injectable version of famotidine Northwell intended to get were secured.

No results have been announced from the study yet. Dr. Kevin Tracey, president of Feinstein Institutes for Medical Research at Northwell Health, told CNN he hopes results from the use of the drug combination could be ready in a few weeks.

The hospital hopes to enroll 1,174 patients in the study, Tracey said.

Tracey told CNN that Northwell Health did not announce any news about the study because the hospital system feared that media attention could lead to a potential run on famotidine.

How does it work?

According to reports from China, famotidine appears to bind to a key enzyme in the COVID-19 virus. Researchers hope the drug will act as a “decoy,” ABC reports, keeping COVID-19 busy, preventing it from spreading throughout the body.

How did they decide on famotidine?

Michael Callahan, an infectious disease physician based at Massachusetts General Hospital in Boston, was in China when the COVID-19 outbreak happened, according to Science Magazine.

As Callahan, along with Chinese doctors, was studying medical histories of patients infected with the virus, they noticed that many survivors had been taking heartburn medication prior to becoming ill with COVID-19.

Callahan said he and his colleagues realized that poorer patients in that group were having better outcomes from the illness. They realized that the poorer patients taking heartburn medication prior to becoming ill had been taking famotidine which is a much less expensive medication.

Callahan noted that wealthier Chinese on heartburn medication did not seem to do as well. Many of those patients had taken medication that cost more than famotidine.

According to Science Magazine, COVID-19 patients on famotidine appeared to be dying at a rate of about 14% compared with 27% for those not on the drug.

However, Tracey told CNN that it is too early to know if famotidine will benefit COVID-19 patients and warned the public not to buy up the medicine and try it at home.

“You should not go to the drugstore and take a bunch of heartburn medicine,” he told CNN.

“People are hoping for anything. But we need to do this clinical trial.”

source: whio.com
Tags: CoronavirusCOVID-19Heartburn

Related Posts

7 Steps to A Healthier You: Beat Heartburn!
Heartburn

7 Steps to A Healthier You: Beat Heartburn!

by admin
February 19, 2023
Say Goodbye to Heartburn and Acid Reflux
Heartburn

Say Goodbye to Heartburn and Acid Reflux

by admin
February 19, 2023
Burn, Baby, Burn!
Heartburn

Burn, Baby, Burn!

by admin
February 19, 2023
GERD or Heartburn? 6 Signs and When to See a Doctor
Heartburn

GERD or Heartburn? 6 Signs and When to See a Doctor

by admin
January 16, 2023

Trending Now

No Content Available

Attention

All the information provided on this website is not intended to replace the medical advice of your doctor or healthcare provider.

Follow Us

Categories

  • Cooking
  • Foods
  • Heartburn
  • Recipes
  • Researches
  • Tips
  • Video
  • Contact
  • About
  • Advertise
  • Privacy & Policy

© 2018 Heartburn Diet | Everything you need to know

No Result
View All Result
  • Home
  • Popular
  • Heartburn
  • Foods
  • Recipes
  • Tips
  • Researches
  • Video

© 2018 Heartburn Diet | Everything you need to know

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.